A detailed history of Headlands Technologies LLC transactions in Repligen Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 14 shares of RGEN stock, worth $2,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$2,043
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$120.0 - $182.95 $1,680 - $2,561
14 New
14 $1,000
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $65,781 - $83,665
474 New
474 $75,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.